-
Ellagic Acid & NAFLD
The results of a randomized, double-blind, placebo-controlled trial investigating the effects of ellagic acid on multiple metabolic markers among people with non-alcoholic fatty liver disease (NAFLD) were recently published in BMC Complementary Medicine and Therapies. This trial enrolled 44 non-obese participants between ages 18 and 55 (mean age ~ 40) diagnosed with NAFLD by hepatic…
-
SIBO & NAFLD – Cause, Effect or Bystander?
A recent review published in Nutrients examines the relationship between small intestinal bacterial overgrowth (SIBO) and non-alcoholic fatty liver disease (NAFLD). This relationship has gained research attention, as a growing body of evidence points to gut microbiota as playing a potentially causal role in NAFLD development and progression, including the promotion of the inflammatory response,…
-
Insights into NAFLD & Cognitive Function
In a recent review published in Cell & Bioscience, many of the common pathologies characteristic of non-alcoholic fatty liver disease (NAFLD) are discussed, as well as how they overlap and contribute to the onset and progression of dementia. To help understand the scope of this problem, it’s worth noting that although the precise prevalence of…